Starting today, July 5 and running until July 20, GHDonline is pleased to host a three session expert panel to discuss the challenges of delivering malaria rapid diagnostic tests in resource limited settings.
In the last decade, millions of malaria rapid diagnostic tests (RDTs) have been implemented worldwide. These simple and easy-to-use tests can diagnose malaria from blood in about 15 minutes, making a laboratory diagnosis possible at all levels of the health care system. While the tests have enabled better access to malaria diagnosis, many challenges still remain.
Session 1 (July 5 to July 10) will address the RDT test and the challenges with interpreting test results in context. What factors can influence the test quality and accuracy and how should these be addressed? Why are quality assurance/quality control programs important in RDTs? Expert panelists leading the discussion in this session include:
• Rosanna Peeling PhD, Chair and Professor of Diagnostics Research at the London School of Hygiene and Tropical Medicine.
• Sandra Incardona, the Technical Officer for Malaria Diagnostics at the Foundation for Innovative and New Diagnostics in Geneva, Switzerland.
Session 2 (July 11 to 14) will highlight challenges with RDTs and health care provider behavior. How have RDTs impacted health provider behavior? What are the implications of “test and treat” guidelines versus presumptive treatment? What do you do when the test is negative? Why is training important to rapid tests? Expert panelists leading the discussion in this session include:
• Wellington Oyibo, an Associate Professor in the College of Medicine at the University of Lagos, Nigeria
• Innocent Ali MSc, is a Poverty Related Diseases Fellow and PhD candidate at the Univeristy of Yaounde I in Cameroon
• Roger Peck, Technical Officer, Immunodiagnostics Portfolio Leader, PATH
Session 3 (July 15 to 20) will focus on policy issues including the assessment, procurement, and financing of RDTs. What regulatory approval should be required? What are challenges to successful implementation? Are RDTs cost-effective? How and where should they be integrated into existing systems? Expert panelists leading the discussion in this session include:
• Larry Barat, Senior Malaria Advisor at the USAID/President’s Malaria Initiative
• Paul Stannard, Deputy Director of Procurement, USAID/Deliver Project
• Megan Moynahan, Senior Advisor for Innovation, Center for Devices and Radiological Health, FDA
Does your organization use malaria RDTs? Do you face challenges that you could share? All GHDonline members can participate in this virtual discussion. Sign up to the community if you haven’t already joined and keep your email settings to “per post” to track the discussion live in your inbox. Each session will be held in a separate discussion thread.
We are looking forward to your participation.